🇰🇷 Revasc in South Korea

Revasc (DESIRUDIN) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Revasc in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in South Korea

Frequently asked questions

Is Revasc approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Revasc in South Korea?

Marathon Pharms Llc is the originator. The local marketing authorisation holder may differ — check the official source linked above.